MGEN - Miragen Therapeutics EPS misses by $0.06 misses on revenue November, 07 2019 04:18 PM Miragen Therapeutics Inc. Miragen Therapeutics (NASDAQ:MGEN): Q3 GAAP EPS of -$0.36 misses by $0.06.More news on: Miragen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...